Literature DB >> 2166776

Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury.

J A Xu1, C Y Hsu, T H Liu, E L Hogan, P L Perot, H H Tai.   

Abstract

Activation of arachidonic acid occurs after spinal cord injury. Leukotriene B4 is a lipoxygenase metabolite of arachidonic acid. In a rat model of experimental spinal cord injury, we found that the leukotriene B4 content was less than the sensitivity of our assay (8 pg/mg of protein) in non-traumatized spinal cord. Leukotriene B4 was detectable in traumatized cord (mean +/- SE, 25 +/- 5 pg/mg of protein; n = 3). Release of leukotriene B4 from spinal cord slices into the incubation medium was also noted after trauma (9 +/- 1 pg/mg of protein; n = 12) and was enhanced by exposure of traumatized spinal cord slices to the calcium ionophore A23187 (375 +/- 43 pg/mg of protein; n = 12). The amount of leukotriene B4 released corresponded to the extent of post-traumatic polymorphonuclear cell infiltration determined by a myeloperoxidase assay. Results from this study suggest that the source of leukotriene B4 in spinal cord injury is infiltrating polymorphonuclear cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166776     DOI: 10.1111/j.1471-4159.1990.tb04577.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury.

Authors:  J Xu; G M Kim; S H Ahmed; J Xu; P Yan; X M Xu; C Y Hsu
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation.

Authors:  K Hirose; K Okajima; Y Taoka; M Uchiba; H Tagami; K Nakano; J Utoh; H Okabe; N Kitamura
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

3.  Upregulation of β-1,4-galactosyltransferase I in rat spinal cord with experimental autoimmune encephalomyelitis.

Authors:  Jianmei Zhao; Ying Gao; Chun Cheng; Meijuan Yan; Jian Wang
Journal:  J Mol Neurosci       Date:  2012-06-16       Impact factor: 3.444

4.  Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes.

Authors:  Y Taoka; K Okajima; M Uchiba; K Murakami; N Harada; M Johno; M Naruo
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

5.  Anti-inflammation effects of Cordyceps sinensis mycelium in focal cerebral ischemic injury rats.

Authors:  Zhenquan Liu; Pengtao Li; Dan Zhao; Huiling Tang; Jianyou Guo
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

6.  The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury.

Authors:  Hirokazu Saiwai; Yasuyuki Ohkawa; Hisakata Yamada; Hiromi Kumamaru; Akihito Harada; Hideyuki Okano; Takehiko Yokomizo; Yukihide Iwamoto; Seiji Okada
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

7.  Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury.

Authors:  Jin-Moo Lee; Ping Yan; Qingli Xiao; Shawei Chen; Kuang-Yung Lee; Chung Y Hsu; Jan Xu
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

Review 8.  Lipid peroxides in the free radical pathophysiology of brain diseases.

Authors:  A A Farooqui; L A Horrocks
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

9.  CYP4Fs expression in rat brain correlates with changes in LTB4 levels after traumatic brain injury.

Authors:  Ying Wang; Jing Zhao; Auinash Kalsotra; Cheri M Turman; Raymond J Grill; Pramod K Dash; Henry W Strobel
Journal:  J Neurotrauma       Date:  2008-10       Impact factor: 5.269

10.  Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury.

Authors:  Jennifer N Dulin; Edward D Karoly; Ying Wang; Henry W Strobel; Raymond J Grill
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.